Copper-metalated peptide palindrome derived from prion octarepeat: synthesis, aggregation, and oxidative transformations

Phased Fiber Growth in a Peptide Conjugate: Aggregation and Disaggregation Studies

A glycine-rich, short pentapeptide conjugate 6, derived from the highly conserved copper-binding octarepeat region of the prion protein, exhibits a tendency to self-aggregate in a time-dependent fashion. Aging of 6 afforded an insight into the phased growth of spherical prefibrillar structures to fibers of long persistence length, as observed by a combination of microscopic techniques. Interestingly, growth of these fibers was inhibited by colchicine, a known inhibitor of microtubule polymerization in a concentration dependent fashion. This study offers an intriguing insight into the occurrence of prefibrillar intermediates on the path to the formation of full length peptide fibers. It is also envisaged that constructs such as 6 may also serve as simple models to study chemical intervention of protein aggregation.

The Copper(II) Adduct of the Unstructured Region of the Amyloidogenic Fragment Derived from the Human Prion Protein is Redox-Active at Physiological pH

Prion diseases are caused by the misfolding and aggregation of the prion protein (PrP). Herein we provide evidence that the CuII adduct of the unstructured amyloidogenic fragment of the human PrP (PrP(91-126)) is redox active under physiological conditions. We have identified that the relevant high-affinity CuII binding region of PrP(91-126) is contained between residues 106 and 114. Both [CuII(PrP(91-126))] and [CuII(PrP(106-114))] have CuII Kd values of approximately 90 microM. Furthermore, the smaller PrP fragment PrP(106-114) coordinates CuII producing an electronic absorption spectrum nearly identical with [CuII(PrP(91-126))] (lambda max approximately 610 nm (epsilon approximately 125 M-1 cm-1)) suggesting a similar coordination environment for CuII. Cu K-edge X-ray absorption spectroscopy (XAS) reveals a nearly identical CuN(N/O)2S coordination environment for these two metallopeptides (2N/O at approximately 1.97 A; 1S at approximately 2.30 A; 1 imidazole N at approximately 1.95 A). Both display quasireversible CuII/CuI redox couples at approximately -350 mV vs Ag/AgCl. ESI-MS indicates that both peptides will coordinate CuI. However, XAS indicates differential coordination environments between [CuI(PrP(91-126))] and [CuI(PrP(106-114))]. These data indicate that [CuI(PrP(91-126))] contains Cu in a four coordinate (N/O)2S2 environment with similar (N/O)-Cu bond distances (Cu-(N/O) r = 2.048(4) A), while [CuI(PrP(106-114))] contains Cu in a four coordinate (N/O)2S2 environment with differential (N/O)-Cu bond distances (Cu-(N/O) r1 = 2.057(6) A; r2 = 2.159(3) A). Despite the differential coordination environments both Cu-metallopeptides will catalytically reduce O2 to O2*- at comparable rates.

Ordering in a glycine-rich peptide conjugate: Microscopic, fluorescence, and metalation studies

Glycine residues play an intriguing role in peptide/protein structure where they can act as tightly packing amino acids with flexible bond angles. For example, structural role of glycines is highlighted in natural silk fibers where different structural polymorphs have been reported. This study deals with a glycine-rich segment from the conserved octarepeat (PHGGGWGQ) in prion protein. We have synthesized a bis-conjugate 3, containing a truncated pentapeptide segment (GGGWG), to study its time-dependent solution phase aggregation by a combination of microscopic methods and fluorescence. This discontinuous peptide conjugate 3 exhibited interesting photophysical properties upon self-assembly allowing us to propose a possible model of peptide filament formation. Taking note of the fact that prion octarepeats bind copper, we also demonstrate the ability of this conjugate to bind copper and the growth and ultrastructure of metallized fibers formed upon incubation. Enforcing peptide fiber formation in metal binding motifs offers an entry into metal impregnated fibers for possible nanobiotechnological applications.